NDC 10139-306-10 - Pamidronate Disodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10139-306
- Requested NDC
- 10139-306-10
- Package NDCs from labels
- 10139-306-10
- Manufacturer
- GeneraMedix, Inc.
- Effective date
- 2009-02-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pamidronate Disodium - GeneraMedix, Inc. | GeneraMedix, Inc. | 2009-02-04 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10139-306-10 | Pamidronate Disodium | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PAMIDRONATE DISODIUM | ACTIVE INGREDIENT | 8742T8ZQZA | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 | |
| PAMIDRONIC ACID | ACTIVE MOIETY | OYY3447OMC | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 | |
| PHOSPHORIC ACID | INACTIVE INGREDIENT | E4GA8884NN | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PAMIDRONATE DISODIUM INJECTION, SOLUTION [GENERAMEDIX, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pamidronate Disodium | PAMIDRONATE DISODIUM | Hospira, Inc. | 9b6a9a3b-71c9-4dcb-b857-5d1de25c3a23 | 2026-05-14 | Warnings, Adverse reactions | 1737449 1737453 |
| Pamidronate Disodium | PAMIDRONATE DISODIUM | Mylan Institutional LLC | c2ca033e-fa5f-4141-b702-11f8b4303da1 | 2025-12-15 | Warnings, Adverse reactions | 1737449 1737453 |
| 12F4C792-52EE-BC0D-FEBD-B393E2814E8F | da574350-be6b-49f3-b2ef-64da06af9b9d | 2009-02-04 | Warnings, Adverse reactions | 12F4C792-52EE-BC0D-FEBD-B393E2814E8F da574350-be6b-49f3-b2ef-64da06af9b9d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.